Correlation Between Sucampo Pharmaceuticals and Amphastar

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sucampo Pharmaceuticals and Amphastar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sucampo Pharmaceuticals and Amphastar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sucampo Pharmaceuticals and Amphastar P, you can compare the effects of market volatilities on Sucampo Pharmaceuticals and Amphastar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sucampo Pharmaceuticals with a short position of Amphastar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sucampo Pharmaceuticals and Amphastar.

Diversification Opportunities for Sucampo Pharmaceuticals and Amphastar

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Sucampo and Amphastar is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sucampo Pharmaceuticals and Amphastar P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amphastar P and Sucampo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sucampo Pharmaceuticals are associated (or correlated) with Amphastar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amphastar P has no effect on the direction of Sucampo Pharmaceuticals i.e., Sucampo Pharmaceuticals and Amphastar go up and down completely randomly.

Pair Corralation between Sucampo Pharmaceuticals and Amphastar

If you would invest (100.00) in Sucampo Pharmaceuticals on January 24, 2024 and sell it today you would earn a total of  100.00  from holding Sucampo Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Sucampo Pharmaceuticals  vs.  Amphastar P

 Performance 
       Timeline  
Sucampo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sucampo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Sucampo Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Amphastar P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amphastar P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Sucampo Pharmaceuticals and Amphastar Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sucampo Pharmaceuticals and Amphastar

The main advantage of trading using opposite Sucampo Pharmaceuticals and Amphastar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sucampo Pharmaceuticals position performs unexpectedly, Amphastar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amphastar will offset losses from the drop in Amphastar's long position.
The idea behind Sucampo Pharmaceuticals and Amphastar P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
CEOs Directory
Screen CEOs from public companies around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account